Article
PD-L1 Polymorphism Can Predict Clinical Outcome of Brazilian Non-Small Cell Lung Cancer Patients After Postoperative Adjuvant Treatment
2020-07-06
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>Although the incidence and mortality of non-small cell lung cancer (NSCLC) remains high with poor prognosis, programmed death‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) pathway are promising prognostic and predictive biomarker of NSCLC. The polymorphisms on <italic>PD‐L1</italic> gene may be associated with their protein expressions and affect the adjuvant tre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5a7153f1-908d-5368-a745-954e2288b56f
- DOI
- 10.21203/rs.3.rs-40075/v1
